JNJ vs PG: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and The Procter & Gamble Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
VS
The Procter & Gamble Company · Consumer Defensive
$147.04
+14.4% upside to fair value
Med Conviction
Grade B+
High Quality
QuantHub Verdict
PG has more upside to fair value
(+14.4%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
PG |
| Current Price |
$270.68 |
$147.04 |
| Fair Value Estimate |
$286.05 |
$168.19 |
| Upside to Fair Value |
+5.7%
|
+14.4%
|
| Market Cap |
$652.3B |
$349.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
20.2x
|
17.6x
|
| Price / Sales |
6.7x
|
4.0x
|
| Price / FCF |
35.3x
|
22.4x
|
| Revenue Growth YoY |
+6.6%
|
+1.5%
|
| Gross Margin |
67.9%
|
50.2%
|
| Operating Margin |
26.8%
|
22.7%
|
| Return on Equity |
25.7%
|
29.8%
|
| Dividend Yield |
1.95% |
2.92% |
| FCF Yield |
2.83%
|
4.47%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
Procter & Gamble is a global consumer-staples leader selling daily-use products across beauty, grooming, health care, fabric and home care, and baby, feminine and family care in about 180 countries. Business quality is high because its brands, consumer insight, R&D, marketing scale and global distribution underpin leading category positions, including over 60% in blades and razors and over 35% in…
Accumulation Zones
| Metric |
JNJ |
PG |
| Zone Low |
$214.54 |
$126.14 |
| Zone High |
$243.14 |
$142.96 |
| In Buy Zone? |
No
|
No
|